5 Myalgic Encephalomyelitis Clinical Trials in Albuquerque, NM (2026)

Q: How do I join a clinical trial in Albuquerque?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Albuquerque research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Albuquerque

NCT06679855Recruiting

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

The goal of this Phase 3, randomized, masked clinical trial is to is to find out whether milrinone, when given to infants after PDA closure, will help the heart work better by supplying oxygen to the ...

Albuquerque, NMPHASE3316 participantsNICHD Neonatal Research Network

View Study Details

NCT06333990Recruiting

Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

A two site, 2-arm, Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual (TAU) medication management for symptoms exp...

Albuquerque, NMPHASE3146 participantsFoundation for Advancing Veterans' Health Research

View Study Details

NCT07436793Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

This phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometri...

Albuquerque, NMPHASE2140 participantsNew Mexico Cancer Research Alliance

View Study Details

NCT06624644Recruiting

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question to be answered is what is the average length of time during ...

Albuquerque, NMPHASE2135 participantsLinnaeus Therapeutics, Inc.

View Study Details

NCT05903131Recruiting

Uterine Preservation Via Lifestyle Transformation

Up to 60% of endometrial cancer cases are attributed to obesity, in part because obesity promotes development of atypical endometrial hyperplasia (AEH), and up to 40% of women with AEH go on to develo...

Albuquerque, NMPHASE296 participantsWashington University School of Medicine

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Albuquerque

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 5 myalgic encephalomyelitis clinical trials recruiting participants in Albuquerque, NM. These studies are seeking a combined 833 participants. Research is being sponsored by NICHD Neonatal Research Network, Foundation for Advancing Veterans' Health Research, New Mexico Cancer Research Alliance and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Albuquerque — FAQ

Are there myalgic encephalomyelitis clinical trials in Albuquerque?

Yes, there are 5 myalgic encephalomyelitis clinical trials currently recruiting in Albuquerque, NM. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Albuquerque?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albuquerque research site will contact you about next steps.

Are clinical trials in Albuquerque free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albuquerque studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 5 active trials in Albuquerque are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated September 4, 2026 from ClinicalTrials.gov